0 Yorumlar
0 hisse senetleri
69 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Europe Non-Small Cell Lung Cancer Diagnostics Market Poised for Growth Amid Advances in Precision Oncology"Executive Summary Europe Non-Small Cell Lung Cancer Diagnostics Market Size and Share Forecast CAGR Value Europe non-small cell lung cancer diagnostics market is expected to reach USD 846.60 million by 2028 from USD 331.31 million in 2020, growing at a steady CAGR of 12.5% in the forecast period of 2021 to 2028. By considering a definite base year and historic year, calculations...0 Yorumlar 0 hisse senetleri 215 Views 0 önizleme
-
Glioblastoma Multiforme Treatment Market Advances with Breakthrough Therapies and Precision Oncology Developments"Executive Summary Glioblastoma Multiforme Treatment Market Size and Share: Global Industry Snapshot CAGR Value Global glioblastoma multiforme treatment market size was valued at USD 3.09 billion in 2024 and is projected to reach USD 6.44 billion by 2032, with a CAGR of 8.90% during the forecast period of 2025 to 2032. For the growth of any business, Glioblastoma Multiforme...0 Yorumlar 0 hisse senetleri 49 Views 0 önizleme
-
Hemato Oncology Testing Market Size, Precision Medicine Trends, and Strategic Industry Outlook 2032"Latest Insights on Executive Summary Hemato Oncology Testing Market Share and Size During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.80% , primarily driven by the rising incidence of blood cancers This Hemato Oncology Testing Market research report proves to be true in serving the purpose of businesses of making enhanced...0 Yorumlar 0 hisse senetleri 391 Views 0 önizleme
-
Hemato Oncology Testing Market Size, Share, Precision Medicine Trends and Strategic Forecast 2032"Executive Summary Hemato Oncology Testing Market Size and Share: Global Industry Snapshot During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.80% , primarily driven by the rising incidence of blood cancers Hemato Oncology Testing Market report offers the most appropriate solution for the business requirements in many ways. To be...0 Yorumlar 0 hisse senetleri 387 Views 0 önizleme
-
Is the Epigenetics-Based Therapeutics Market Transforming Precision Medicine and Oncology?"Executive Summary Epigenetics-Based Therapeutics Market Research: Share and Size Intelligence CAGR Value The global epigenetics-based therapeutics market size was valued at USD 1.76 billion in 2024 and is expected to reach USD 5.17 billion by 2032, at a CAGR of 14.40% during the forecast period The all-inclusive Epigenetics-Based Therapeutics...0 Yorumlar 0 hisse senetleri 62 Views 0 önizleme
-
Kidney Cancer Diagnostics Market – Precision Oncology Tools, Early Detection Technologies & Clinical Accuracy"Executive Summary Kidney Cancer Diagnostics Market: Growth Trends and Share Breakdown CAGR Value Data Bridge Market Research analyzes that the kidney cancer diagnostics market is expected to reach a value of USD 16,862.32 million by 2030, at a CAGR of 6.4% during the forecast period. The key highlights of this Kidney Cancer Diagnostics Market report are key market dynamics, the current...0 Yorumlar 0 hisse senetleri 266 Views 0 önizleme
-
Myeloid Leukemia Treatment Market – Precision Oncology Advancements & Drug Development Acceleration"Global Executive Summary Myeloid Leukemia Treatment Market: Size, Share, and Forecast CAGR Value Data Bridge Market Research analyses a growth rate in the myeloid leukemia treatment market in the forecast period 2023-2030. The market is expected to reach USD 34.30 billion by 2030, which is USD 16 billion in 2022, and is expected to undergo a CAGR of 10% during the forecast period 2023...0 Yorumlar 0 hisse senetleri 234 Views 0 önizleme
-
Oral HER Pathway Targeted Drugs Market Advances with Precision Oncology Breakthroughs"Executive Summary Oral HER Pathway Targeted Drugs Market Research: Share and Size Intelligence CAGR Value The global oral HER pathway targeted drugs market size was valued at USD 6.24 billion in 2025 and is expected to reach USD 15.01 billion by 2033, at a CAGR of 11.60% during the forecast period This Oral HER Pathway Targeted Drugs Market...0 Yorumlar 0 hisse senetleri 11 Views 0 önizleme
-
Oral HER Pathway Targeted Drugs Market Surges with Advancements in Precision Oncology"Executive Summary Oral HER Pathway Targeted Drugs Market: Share, Size & Strategic Insights CAGR Value The global oral HER pathway targeted drugs market size was valued at USD 6.24 billion in 2025 and is expected to reach USD 15.01 billion by 2033, at a CAGR of 11.60% during the forecast period The Oral HER Pathway Targeted Drugs report provides...0 Yorumlar 0 hisse senetleri 94 Views 0 önizleme
-
Precision Oncology and the Evolution of Molecular Diagnostics in the U.S.Among the most dependable areas of healthcare investment stands the global US Molecular Diagnostics market within the medical device industry, with the greatest transformative capacity for expansion and innovation. A modern healthcare setup reflects advances in the equipment to enable quick treatments and pinpoint accuracy in results. The global US Molecular...0 Yorumlar 0 hisse senetleri 383 Views 0 önizleme
-
Precision Oncology: Competitive Dynamics and Patient-Centric Growth in the Anastrozole Market"Executive Summary Anastrozole Tablets Market Size and Share Across Top Segments The global anastrozole tablets market size was valued at USD 410.71 million in 2025 and is expected to reach USD 512.25 million by 2033, at a CAGR of 2.80% during the forecast period Analysis and discussion of important industry trends, market size, and market share are...0 Yorumlar 0 hisse senetleri 11 Views 0 önizleme
-
High Potency Active Pharmaceutical Ingredients Market to Reach USD 66.38 Billion by 2033, Growing at 9.37% CAGRMarket Overview The global high potency active pharmaceutical ingredients market size was valued at USD 29.64 billion in 2024 and is projected to grow from USD 32.42 billion in 2025 to reach USD 66.38 billion in 2033, growing at a CAGR of 9.37% during the forecast period (2025–2033). The global High Potency Active Pharmaceutical Ingredients market...0 Yorumlar 0 hisse senetleri 523 Views 0 önizleme
-
Linear Particle Accelerators Market Opportunities: Growth, Share, Value, Size, and Scope"Comprehensive Outlook on Executive Summary Linear Particle Accelerators Market Size and Share Global linear particle accelerators market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account from USD 2,346.51 million in 2020 to USD 3,672.77 million by 2028 growing at a CAGR of 5.76% in the above-mentioned...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Spatial Genomics and Transcriptomics Market Future Scope: Growth, Share, Value, Size, and Analysis"Executive Summary Spatial Genomics and Transcriptomics Market Size and Share: Global Industry Snapshot The global spatial genomics and transcriptomics market size was valued at USD 1.22 billion in 2024 and is projected to reach USD 11.36 billion by 2032, with a CAGR of 21.30% during the forecast period of 2025 to 2032. Spatial Genomics and Transcriptomics Market report offers...0 Yorumlar 0 hisse senetleri 6K Views 0 önizleme
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Yorumlar 0 hisse senetleri 12 Views 0 önizleme
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Yorumlar 0 hisse senetleri 13 Views 0 önizleme
Arama Sonuçları
English
Kiswahili
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
